Rationale: Cardiac progenitor cells from the second heart field (SHF) contribute to rapid growth of the embryonic heart, giving rise to right ventricular and outflow tract (OFT) myocardium at the arterial pole of the heart, and atrial myocardium at the venous pole. Recent clonal analysis and cell-tracing experiments indicate that a common progenitor pool in the posterior region of the SHF gives rise to both OFT and atrial myocytes. The mechanisms regulating deployment of this progenitor pool remain unknown. Objective: To evaluate the role of TBX1, the major gene implicated in congenital heart defects in 22q11.2 deletion syndrome patients, in posterior SHF development. Methods and Results: Using transcriptome analysis, genetic tracing, and fluorescent dye-labeling experiments, we show that Tbx1-dependent OFT myocardium originates in Hox-expressing cells in the posterior SHF. In Tbx1 null embryos, OFT progenitor cells fail to segregate from this progenitor cell pool, leading to failure to expand the dorsal pericardial wall and altered positioning of the cardiac poles. Unexpectedly, addition of SHF cells to the venous pole of the heart is also impaired, resulting in abnormal development of the dorsal mesenchymal protrusion, and partially penetrant atrioventricular septal defects, including ostium primum defects. Conclusions: Tbx1 is required for inflow as well as OFT morphogenesis by regulating the segregation and deployment of progenitor cells in the posterior SHF. Our results provide new insights into the pathogenesis of congenital heart defects and 22q11.2 deletion syndrome phenotypes. (Circ Res. 2014;115:790-799.)
A major part of the vertebrate heart is formed by progressive addition of second heart field (SHF) cardiac progenitor cells, situated in splanchnic pharyngeal mesoderm, to the poles of the elongating heart tube. At the arterial pole of the heart, the SHF contributes to myocardium of the right ventricle and outflow tract (OFT). At the venous pole, the SHF contributes to atrial myocardium and the dorsal mesenchymal protrusion (DMP), also known as the vestibular spine, required for the formation of separate right and left atrioventricular junctions. [1] [2] [3] Research into SHF biology is driven by the discovery that perturbation of SHF development results in a spectrum of congenital heart defects (CHD) contributing significantly to morbidity and mortality. 4, 5 In This Issue, see p 751
Retrospective clonal analysis has recently shown that OFT myocardium at the base of the pulmonary trunk, or subpulmonary myocardium, is clonally related to myocardium at the venous pole of the heart. 6 Consistent with this finding, fluorescent dye-labeling experiments analyzing the fate of cells in the posterior SHF, close to the venous pole, revealed a contribution to OFT as well as atrial myocardium. 7 Moreover, Cre-mediated genetic tracing revealed that Hox gene-expressing cells in the posterior SHF contribute to atrial and subpulmonary OFT myocardium. 8 Together, these experiments suggest that a common population of progenitor cells in the posterior SHF gives rise to both venous pole and subpulmonary OFT myocardium. The genetic and cellular mechanisms by which this common progenitor cell population is deployed to the cardiac poles are currently unknown.
TBX1, encoding a T-box-containing transcription factor, is the major candidate gene for 22q11.2 deletion syndrome (22q11.2DS, also known as DiGeorge or Velo-cardio-facial syndrome), associated with craniofacial and cardiovascular defects, in particular those involving the OFT. 9 Tbx1 is expressed in endoderm, ectoderm, and mesoderm in the pharyngeal region and is required in pharyngeal mesoderm for OFT development, where it regulates SHF proliferation and differentiation, resulting in failure to elongate the distal OFT and common arterial trunk in Tbx1 −/− embryos. [10] [11] [12] [13] Tbx1-expressing progenitor cells have been shown to contribute to the inferior and lateral walls of the OFT and subpulmonary myocardium of the fetal heart 14, 15 ; altered regional transgene expression has shown that this myocardial domain is reduced in the common arterial trunk of Tbx1 −/− hearts. 16 Furthermore, reduction of subpulmonary myocardium has been proposed to be an early event in the pathogenesis of tetralogy of Fallot, the most prevalent CHD observed in TBX1 haploinsufficient 22q11.2DS patients. 17, 18 Here, we use transcriptional profiling, genetic lineage tracing, DiI labeling experiments, and 3-dimensional (3D) reconstructions to show that Tbx1 is required for the addition of Hox gene-expressing progenitor cells from the posterior SHF to the arterial pole of the heart. Unexpectedly, the addition of progenitor cells from the posterior SHF to the venous pole is also impaired in Tbx1 −/− hearts, resulting in abnormal development of the DMP and consequent atrioventricular septal defects (AVSDs), including ostium primum defects. Our results highlight the significance of SHF development and deployment in the origin of common forms of CHD and provide new insights into the spectrum of CHD in 22q11.2DS patients.
Methods

Transgenic Mouse Lines
The following mouse lines were used: Tbx1 tm1Pa (Tbx1 − ), 12 Mlc1v-nlacZ- 24, 19 Gtrosa26 tm1Sor 20 , Tg(Mef2c-cre)2Blk, 21 Hoxb1-Cre, and Hoxa1-enhIII-Cre. 8 Mice were maintained on mixed (C57Bl/6 and CD1) and inbred (FVB/N) backgrounds. Animal care was in accordance with national and institutional guidelines.
In Situ Hybridization, Immunohistochemistry, and β-Galactosidase Detection
In situ hybridization, fluorescent immunohistochemistry, and detection of β-galactosidase activity were performed as described. 22 Antibodies used are detailed in the Online Data Supplement.
Microarray Gene Expression Analysis
Inferior OFT (iOFT) and superior OFT (sOFT) regions were dissected from E10.5 CD1 mouse embryos, as detailed in the Online Data Supplement. The screen was performed with biological triplicates using Affymetrix 430 2.0 mouse arrays. Microarray data were analyzed using Limma and Affy Bioconductor packages. 23 Quantitative real-time polymerase chain reaction validation was performed according to standard techniques. The microarray data are available from the National Centre for Biotechnology Information Gene Expression Omnibus repository (accession number GSE57951).
DiI Injection and Embryo Culture
E8.5 embryos were labeled by injection of a fluorescent lipophilic cationic indocarbocyanine dye, DiI (1,1'-dioctadecyl-3,3,3'3'-tetramethylindocarbocyanine perchlorate). DiI was injected into the caudal part of the dorsal pericardial wall and cultured as described previously. 7
Three-Dimensional Visualization of Gene Expression and Morphometry
Acquisition and 3D reconstruction of gene expression patterns using AMIRA software (TGS Template Graphics Software, http://www.tgs. com) was performed using a previously described method. 24
High-Resolution Episcopic Microscopy
High-resolution episcopic microscopy was performed as described. 25 Three-dimensional reconstructions of the datasets were obtained and analyzed using OsiriX 3.8.
Results
Analysis of the Genetic Signature of Future Subpulmonary Myocardium
Despite its clinical importance as a CHD hotspot, the genetic networks regulating the development of subpulmonary myocardium are poorly understood. To characterize the genetic signature of future subpulmonary myocardium, 26 we performed microarray-based gene expression profiling of inferior and superior walls of the distal OFT at E10.5 (iOFT and sOFT, respectively). The majority of transcripts expressed in the OFT at this stage accumulate equivalently in the iOFT and sOFT ( Figure 1A ). However, 211 probe sets corresponding to 181 genes yielded a significantly higher signal in the iOFT (fold change >1.3; P<0.05), including 25 genes detected by ≥2 probe sets (Online Table I ). A total of 18 iOFT-enriched genes showed >1.7-fold changes (Table) . These include Sema3c, detected by 2 of the top iOFT-enriched probe sets, encoding a Semaphorin ligand required for neural crest influx into the OFT. 27 Sema3c expression was previously shown to be enriched in this part of the heart, 16 providing a positive experimental control. iOFTenriched transcripts included genes encoding NRP2, a receptor protein with roles in cardiovascular development that binds to SEMA3c, 28 EFHD1, involved in neural differentiation, 29 BARX1 and DLX2, transcription factors important for the development of neural crest-derived mesenchyme, 30, 31 and the nuclear receptor PPARG. The iOFT enrichment of selected genes, including Nrp2, Barx1, Dlx2, and PParg, was validated by quantitative reverse transcription polymerase chain reaction, revealing 1.5-to 4-fold higher transcript levels in the iOFT ( Figure 1B ). In situ hybridization confirmed that, as for Sema3c, transcripts for Nrp2, Barx1, Dlx2, and additional iOFT-enriched genes (G0S2 and Ltbp2) accumulate in the iOFT myocardial wall ( Figure 1C ; Online Figure I Figure I ). 32 This is likely to reflect inclusion of epicardial cells in microdissected sOFT material, as in situ hybridization revealed earlier expansion of Tbx18-expressing epicardial cells over the sOFT wall at E10.5 (Online Figure I ).
Tbx1 Dependency of Future Subpulmonary Myocardium
Expression of Sema3c is downregulated in the Tbx1 −/− OFT. 16 We evaluated the Tbx1 dependency of the newly identified iOFT-enriched genes by in situ hybridization. Loss of Nrp2, Barx1, and Dlx2 transcript accumulation was observed in the inferior OFT wall of Tbx1 −/− embryos ( Figure 1C ). In contrast, a broader distribution of sOFT-enriched genes was observed (Online Figure  I ). Quantitative reverse transcription polymerase chain reaction confirmed a significant decrease in Sema3c, Nrp2, Barx1, and G0S2 transcript levels in the Tbx1 −/− OFT (Online Figure I) . In Tbx1 +/− embryos, Sema3c, Nrp2, and G0S2 transcript levels were unaltered, suggesting that TBX1 is not a limiting transcriptional activator of these genes; in contrast, Barx1 levels were decreased (Online Figure I) . Given that Tbx1 −/− embryos display distal OFT hypoplasia, these results suggested that TBX1 may be required for addition of future subpulmonary myocardial cells to the OFT. To test this hypothesis, genetic tracing experiments were performed using a Hoxb1 IRES-Cre allele expressed in subpulmonary myocardial progenitor cells in the posterior SHF. 8 Hoxb1 IRES-Cre ;Tbx1 +/− mice were crossed with R26R-lacZ;Tbx1 +/− reporter mice. Although Hoxb1 expression is maintained in pharyngeal mesoderm of Tbx1 −/− embryos (Online Figure II) , the Tbx1 −/− OFT is negative for Hoxb1-Cre-labeled cells with the exception of a small number of cells in the inferior wall (Figure 2A ). At fetal stages, Hoxb1 IRES-Cre ;R26R embryos express β-galactosidase in myocardium at the base of the pulmonary trunk. In E14.5 Tbx1 −/− hearts, Hoxb1-Cre-labeled cells were not observed in the ventral region, consistent with failure of subpulmonary myocardial development ( Figure 2B ). In contrast, Hoxb1-Cre-labeled cells contribute to the arterial walls and atrial myocardium in both Tbx1 −/− and wild-type hearts (Figure 2A and 2B). Hoxa1 is expressed in a subpopulation of Hoxb1-expressing cells in the subpulmonary myocardial lineage. 8 We investigated the distribution of cells derived from Hoxa1-expressing progenitors in Tbx1 −/− embryos using a Hoxa1-enhIII-Cre line ( Figure 2C ). In contrast to wild type, no labeled cells were observed in myocardium of the OFT or common arterial trunk of Tbx1 −/− hearts ( Figure 2C ). However, unlike Hoxb1, Hoxa1 transcript accumulation was reduced in posterior pharyngeal mesoderm and surface ectoderm of Tbx1 −/− embryos (Online Figure II) . Taken together, these data reveal compromised contribution of Hoxexpressing subpulmonary myocardial progenitor cells from the posterior SHF to the elongating Tbx1 −/− OFT.
Tbx1 Deficiency Affects Movement of Cells From the Posterior SHF Toward the Arterial Pole of the Heart From Somite Stage 7 Onward
We next examined the fate of cells in the posterior region of the SHF in wild-type and Tbx1 −/− embryos using DiI tracing experiments ( Figure 3A ). Cells were labeled with DiI in the dorsal pericardial wall of 4 to 8 somite stage E8.5 embryos (t0) at the level of the posterior expression limit of the Fgf10 enhancer trap transgene, Mlc1v-nlacZ-24, expressed in arterial pole progenitor cells ( Figure 3B ). Embryos were cultured for 18 hours (t18; Figure 3A ) and the anterior limit of DiIlabeled cells scored with respect to anterior and posterior regions of pharyngeal mesoderm between the arterial and venous poles ( Figure 3C ). In wild-type and Tbx1 +/− embryos, the majority of labeling events resulted in labeled cells close to the arterial pole of the heart, including cells in the distal OFT ( Figure 3D ; Online Figure III) , consistent with the recent finding that posterior SHF cells contribute to the OFT. 7 The results obtained for Tbx1 −/− embryos labeled before the 7-somite stage were indistinguishable from those for control embryos ( Figure 3D ; Online Figure III ). In contrast, in Tbx1 −/− embryos with ≥7 somites, labeled cells failed to contribute anteriorly and were found close to the inflow of the heart ( Figure 3D ; Online Figure III) . These results suggest that, in the absence of TBX1, the movement of cells in the dorsal pericardial wall toward the arterial pole fails from the 7-somite stage onward.
Tbx1 Deficiency Affects Expansion of the SHF Progenitor Pool in the Dorsal Pericardial Wall and Positioning of the Cardiac Poles
We next investigated how failure of cells in the posterior region of the SHF to segregate to the arterial pole of Tbx1 −/− embryos affects the morphology of the dorsal pericardial wall using 3D reconstructions. The dorsal pericardial wall of Tbx1 −/− embryos was significantly shortened at E9.5 ( Figure 4A ), associated with a reduction of Fgf10 enhancer trap transgene-expressing cells 33 ( Figure 4B ). The dorsal pericardial wall of Tbx1 −/− embryos contains cells that abnormally activate the myocardial differentiation program. 10, 11 Expanded NKX2-5 expression and ectopic differentiation, revealed by cardiac Troponin I expression, are restricted to the medial dorsal pericardial wall connecting the cardiac poles in Tbx1 −/− embryos (Online Figure IV) . Three-dimensional reconstruction of E10.5 hearts and quantification using AMIRA software reveal that the poles of the heart are significantly closer than in wild-type embryos ( Figure 4C and 4D). Failure of deployment of progenitor cells from the posterior SHF toward the arterial pole of the heart in Tbx1 −/− embryos thus results in hypoplasia of the dorsal pericardial wall and abnormal juxtaposition of the cardiac poles. Consequently, the venous pole of the heart is positioned dorsally relative to the more caudal position in wild-type embryos ( Figure 4C ).
Posterior SHF Development in Tbx1 −/− Embryos
Cardiac progenitor cells in the posterior SHF give rise to atrial myocardium at the venous pole of the heart, including the base of the developing atrial septum. [34] [35] [36] Anomalies of the venous pole in Tbx1 −/− embryos have not been reported previously. Nonetheless, given that cells from the posterior SHF fail to contribute to the dorsal pericardial wall and iOFT in Tbx1 −/− embryos, we investigated gene expression and progenitor cell distribution in the posterior SHF of mutant embryos. The transcription factor TBX5 is required in the posterior SHF for atrial and venous pole development. 37, 38 Tbx5 transcripts have been shown to accumulate in a broader region of the dorsal pericardial wall of Tbx1 −/− embryos. 10 We used immunofluorescence and 3D reconstruction to compare TBX5 and Fgf10-nlacZ transgene expression in wild-type and Tbx1 −/− embryos ( Figure 5 ). TBX5 and Fgf10-nlacZ identify reciprocal posterior/medial and anterior/lateral domains in the wild-type dorsal pericardial wall at E9.5 ( Figure 5A and 5B ). In the absence of TBX1, we observed that TBX5 and Fgf10-nlacZ colocalize in the posterior SHF adjacent to the venous pole, in particular, on the right side of the embryo (Figure 5A and 5B) . Consistent with the juxtaposition of the cardiac poles, the TBX5-positive domain is positioned more dorsally and closer to the arterial pole of Tbx1 −/− hearts, relative to the caudal expression domain in wild-type embryos ( Figure 5B ; Online Figure V) . Similar results were obtained for Tbx5 transcripts, as well as those of the TBX5 target gene Osr1 38 (Online Figure V) . These experiments reveal abnormal gene expression profiles and progenitor cell distribution in the posterior SHF of Tbx1 −/− embryos.
Abnormal Development of the DMP Results in AVSDs in Tbx1 −/− Embryos
We subsequently investigated posterior SHF contributions to the venous pole of Tbx1 −/− hearts. The DMP is an Isl1-expressing SHF derivative that forms on the dorsal side of the atrial component of the primary heart tube at E10.5 and contributes to the atrioventricular mesenchymal complex. 35, 39, 40 Defects in dorsal mesocardial development at the venous pole of Tbx1 −/− embryos were observed, including increased expression of differentiation markers in the adjacent dorsal pericardial wall ( Figure 6A ). The abnormal dorsally and anteriorly constrained venous pole of mutant hearts is associated with a failure of undifferentiated ISL1-positive mesenchyme to protrude maximally into the atrial cavity of Tbx1 −/− hearts ( Figure 6B ). In wild-type E11.5 hearts, the DMP can be distinguished as a prong of ISL1-positive mesenchyme forming the right border of the developing pulmonary veins, continuous with the inferior commissure of the venous valves, and connecting with the inferior atrioventricular endocardial cushion ( Figure 6C ). In Tbx1 −/− hearts a hypoplastic DMP, identified by ISL1-positive mesenchyme connected to the inferior endocardial cushion, could be observed ( Figure 6C ). A hypoplastic DMP was also observed in Tbx1 −/− hearts at E12.5 in 3D reconstructions generated using high-resolution episcopic microscopy ( Figure 6D) . The DMP plays a critical role in bridging the mesenchymal cap of the primary atrial septum with the inferior atrioventricular cushion, ultimately giving rise to the muscular base of the atrial septum. Hypoplasia of the DMP has been implicated in formation of AVSDs, including ostium primum defects. 3, [40] [41] [42] Analysis of 37 Tbx1 null hearts by histology and HREM between E14.5 and E18.5 revealed AVSDs in 13 hearts (35%), whereas no such defects were observed in 20 hearts from wild-type littermates (Figure 7 ; P<0.005) or in 9 Tbx1 +/− hearts. The spectrum of AVSDs observed in Tbx1 −/− hearts ranges from primum defects, with separate valvar orifices within the common atrioventricular junction for the right and left ventricles, to those with a common valve guarding the common junction, the latter having additional defects between the ventricular surface of the bridging leaflets of the common valve and the crest of the muscular ventricular septum (Figure 7) . In contrast to the variable penetrance of AVSDs in mutant embryos, common arterial trunks were observed in all Tbx1 −/− hearts ( Figure 7B and 7C) . Genetic tracing was used to test the hypothesis that AVSDs in Tbx1 −/− hearts result from failure of the DMP to contribute sufficiently to the atrioventricular septal complex. The Mef2c-AHF-Cre transgene is expressed in progenitor cells contributing to the DMP at the venous pole of the heart. 3, 36, 38 In wild-type hearts at E15.5, Mef2c-Cre-labeled cells are observed in the primary atrial septum and in mesenchymal cells of the DMP at the base of the primary atrial septum, contiguous with mesenchyme bridging the interventricular septum ( Figure 7D ). An example of a Tbx1 −/− heart with AVSD is shown in Figure 7D . Mef2c-Cre-labeled cells can be observed in the atrial septum but not in mesenchyme bridging the ventricular septum, consistent with failure of DMP development ( Figure 7D ). Impaired addition of SHF cells to the venous pole of Tbx1 −/− hearts thus leads to AVSDs in one third of mutant hearts, providing the first evidence that TBX1 is required for progenitor cell deployment to the venous pole of the heart.
Discussion
Elongation of the embryonic heart is driven by addition of SHF cells to the cardiac poles. In this study, we show that TBX1 regulates the deployment of Hox-expressing progenitor cells in the posterior SHF to both poles of the heart tube. Tbx1 was previously considered to be required only for OFT development: the OFT of Tbx1 −/− embryos is hypoplastic at E10.5 and fails to divide during early fetal development because of impaired migration of cardiac neural crest cells. 10, 13, 16, 22, 43, 44 Regional transgene analysis has shown that the hypoplastic OFT has a reduced myocardial domain normally observed at the base of the pulmonary trunk. 16 The clinical significance of subpulmonary myocardium is reflected by the incidence of CHDs affecting this region of the heart, notably tetralogy of Fallot with either pulmonary stenosis or pulmonary atresia. 4, 17 Here, we show that future subpulmonary myocardium displays a distinct genetic signature in the iOFT wall, characterized by the enriched expression of several genes required for neural crest development, migration, and chemotaxis. These include genes encoding SEMA3C, a signaling molecule required for axonal guidance and cardiac neural crest influx into the OFT, 27 NRP2, a coreceptor of SEMA3C, 28 BARX1 and DLX2, required in neural crest-derived mesenchyme during craniofacial morphogenesis, 30,31 EFDH1, required for neurite outgrowth during neuron projection development, 29 and PPARG, recently shown to affect neural crest cell fate in zebrafish embryos. 45 Thus, many of the genes enriched in the iOFT are required for or have the potential to facilitate the influx of cardiac neural crest cells into the OFT and contribute to OFT septation. Furthermore, the expression of iOFT-enriched genes is severely reduced or absent in Tbx1 −/− embryos in which the OFT fails to divide. Together with Hox-Cre and DiI-labeling experiments, this result demonstrates that the addition of a transcriptionally distinct future subpulmonary myocardial domain to the OFT is Tbx1 dependent. This does not rule out direct regulation of a subset of iOFT-enriched genes by TBX1; indeed, we observed reduced Barx1 transcript levels in the Tbx1 +/− OFT and reduced Hoxa1 transcript accumulation in Tbx1 −/− embryos. Decreased expression of genes normally enriched in the developing iOFT could contribute to the pathogenesis of human CHD affecting the developing OFTs, including tetralogy of Fallot and common arterial trunk. These iOFT-enriched transcripts thus identify new candidate genes for mutation screens investigating the genetic basis of OFT malformations. In strong support of such a conclusion, BARX1 has been identified recently as a candidate gene in tetralogy of Fallot based on a systematic screen for rare polymorphisms in human patients. 46 Recent evidence has shown that progenitor cells in the posterior SHF contribute to both future subpulmonary myocardium and the venous pole of the heart. [6] [7] [8] Here, we identify TBX1 as a regulator of this process. Hoxb1-expressing progenitor cells in the posterior SHF fail to contribute, or contribute minimally, to the short narrow OFT of Tbx1 −/− embryos. Furthermore, anterior displacement of progenitor cells from the posterior SHF fails from the 7-somite stage (E8.5), consistent with the results of elegant conditional loss of function experiments defining the temporal requirement for Tbx1 in OFT development. 47 Failure of OFT progenitor cells to arise from the posterior SHF results in hypoplasia of the dorsal pericardial wall in Tbx1 −/− embryos. Fgf10-nlacZ transgene and TBX5 expression, normally restricted to the anterior and posterior SHF, respectively, overlap in Tbx1 −/− embryos. This suggests that TBX1 is required to establish a boundary between anterior and posterior SHF domains, potentially by regulating progenitor cell segregation to the arterial versus venous pole. Consistent with such a role, Tbx1-Cre genetic tracing studies have shown that Tbx1-positive progenitor cells give rise not only to OFT myocardium but also to venous pole structures, including the primary atrial septum and DMP. 14, 15 Tbx1 is thus expressed in a common population of progenitor cells before allocation to the arterial or venous poles. Future experiments will dissect the target genes and regulatory networks downstream of TBX1 that are involved in the segregation of future subpulmonary myocardium from the posterior SHF.
The DMP, or vestibular spine, originally described by His, protrudes into the atrial lumen to contribute to the atrioventricular mesenchymal complex and muscular base of the atrial septum. 3, 35, 39, 40 Perturbation of DMP development in embryos mutant for transcription factors and signaling molecules regulating posterior SHF deployment results in AVSDs, including ostium primum defects. 36, 38, [48] [49] [50] In Tbx1 −/− hearts the DMP is hypoplastic from E10.5 when it first protrudes into the atrial cavity. This small DMP, although contacting the inferior atrioventricular cushion mesenchyme, seems insufficient to partition the atrioventricular junction in Tbx1 −/− embryos. As a result, approximately one third of Tbx1 −/− embryos analyzed at fetal stages displayed AVSDs of variable severity. Although the role of the TBX1 during OFT development has been vigorously explored, inflow CHDs have not been reported previously. 9 This may be because of incomplete phenotypic penetrance (35%, versus 100% for common arterial trunk), suggesting the existence of genetic modifiers of the penetrance of AVSDs in Tbx1 −/− embryos. Defective SHF contributions to the DMP are emerging as a new paradigm for the pathogenesis of AVSDs. 3, 38 Our results position TBX1 within the gene regulatory network required for DMP development and atrioventricular septation. Defects in progenitor cell proliferation or precocious myogenic differentiation have been implicated in failure of DMP development in other mouse models. 36, 38, 50 TBX1 regulates both proliferation and differentiation in the SHF, failure of which may contribute to DMP defects in Tbx1 −/− embryos 10, 11 ; indeed, we observed abnormal differentiation in the dorsal pericardial wall adjacent to the DMP at E10.5. Our findings illustrate how early events in the SHF, including the expansion and segregation of progenitor cell populations in the posterior SHF, can prefigure CHDs affecting both poles of the heart. AVSDs are observed rarely (1%-4%) in TBX1 haploinsufficient 22q11.2DS patients, where OFT malformations dominate. 18 The finding that Tbx1 is required for posterior SHF cells to contribute to both poles of the heart tube suggests an explanation for the occurrence of venous pole defects in 22q11.2DS patients, in addition to providing the first insights into the regulation of cardiac progenitor cell segregation in the SHF.
What Is Known?
• The embryonic heart grows by addition of second heart field cardiac progenitor cells to the arterial and venous poles. • The transcription factor TBX1, encoded by the 22q11.2 deletion (DiGeorge) syndrome candidate gene, is a pivotal regulator of second heart field cell addition to the arterial pole. • Recent findings suggest that a common progenitor cell population contributes to both poles of the heart.
What New Information Does This Article Contribute?
• The genetic signature of TBX1-dependent arterial pole myocardium is defined. • TBX1-dependent arterial pole myocardium originates in Hoxexpressing progenitor cells in the posterior second heart field close to the venous pole of the heart. • TBX1 is also required for second heart field cell addition to the venous pole of the heart and atrioventricular septal defects are observed in TBX1-deficient embryos.
Deciphering the mechanisms regulating second heart field progenitor cell addition to the cardiac poles is a requisite step to understand the pathogenesis of common congenital heart defects. A population of second heart field cells contributing to both poles of the heart has been identified recently although its regulation remains obscure. Here, we show that the 22q11.2 deletion (DiGeorge) syndrome gene TBX1 coordinates addition of this common progenitor cell pool to the elongating heart. Loss of function of TBX1 results in atrioventricular septation defects as well as arterial pole anomalies. This is the first evidence for a role of TBX1 in venous pole morphogenesis and implicates this transcription factor in an emerging network of regulators of second heart field addition to the base of the atrial septum, perturbation of which results in ostium primum and atrioventricular septal defects. Moreover, our results provide new insights into the segregation of divergent fates in the second heart field and the spectrum of congenital heart defects observed in 22q11.2 deletion syndrome patients.
Novelty and Significance
